Biointelect retweeted
NOVAVAX APPROVED: Nuvaxovid is the first protein-based COVID-19 vaccine registered for use as a booster in Australia.
Novavax, Inc today announced the TGA has granted provisional registration of the Nuvaxovid COVID-19 vaccine as a booster in individuals aged 18 and over. #9News
Biointelect retweeted
Novavax will be giving six different presentations showcasing our vaccine data at Australia's Communicable Diseases & Immunisation Conference, #CDIC2022. Learn more: bit.ly/3Hug1IZ
Biointelect retweeted
This next episode we discuss with Jennifer Herz from #Biointelect how she and Karl Herz from #Biocelect established their #relationship with @novavax leading to Biocelect being their sponsor for the #covid19vaccine in Australia and New Zealand
Biointelect retweeted
In this week of #ICYMI - we feature activities from our CEO @DrDanGrant, our GM Stakeholder Engagement Dr Alfredo Martinez-Coll and our Director Major Projects @ElizabethStares mtpconnect.org.au/Story?Acti…
Biointelect retweeted
ISG opened by @ProfPCDoherty #ASM2018
Biointelect retweeted
63% reduction in infant influenza after maternal vaccination in pregnancy @SaadOmer3 #NCIRS20YR bit.ly/2xSE0g6
Biointelect retweeted
ThankU @BiointelectInfo for inviting @PHE_uk to #ausbio17 & to fellow speakers @jmcvernon, @Certara's Leigh Farrell, @nhmrc's David Abbott
Biointelect retweeted
Replying to @AusBiotech
@ausbiotech convention #AusBio17 begins at #Adelaide -- @PHE_UK is proud to be back! Meet us the speaker slot chaired by @BiointelectInfo


















